(MedPage Today) — The FDA approved a tumor treating fields (TTFields) device for locally advanced pancreatic cancer, the first therapy approved in this setting in nearly 30 years.
Dubbed Optune Pax, the wearable device delivers alternating electric…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/119854
Author :
Publish date : 2026-02-12 18:00:00
Copyright for syndicated content belongs to the linked Source.
